New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Entourage Health Corp.
ENTG.V
Shape
US Flag

TSXV

Unprofitable

EPS improving

Unprofitable

EPS improving

3M

Drug Manufacturers - Specialty & Generic

Next Earning date - 25 Nov 2024

3M

Drug Manufacturers - Specialty & Generic

Next Earning date - 25 Nov 2024

0.01CAD
Shape-0.01 ( -33.33%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

7%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

50%

Quote Panel

Shape
Updated October 2, 2024
1W 0.00 % 1M 0.00 % 3M 0.00 % 1Y -50.00 %

Key Metrics

Shape
  • Market Cap

    3.08M


  • Shares Outstanding

    308.39M


  • Share in Float

    246.35M


  • Dividende

    0


  • Earning Date

    25 Nov 2024


  • Price Target

    0.01


  • Average Volume

    48985


  • Beta

    1.132


  • Range

    0.01-0.02


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://entouragehealthcorp.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.08x

P/S Ratio

-0.02x

P/B Ratio

-1.1

Debt/Equity

-107.4%

Net Margin

$-0.1

EPS

How ENTG.V compares to sector?

P/E Ratio

Relative Strength

Shape

ENTG.V

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$132M

Shape1330%

2025-Revenue

$0.10

Shape399%

2025-EPS

$92M

Shape-2605%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.03
vs NA

Q2.22

arrow
arrow

N/A

-0.06
vs -0.08

Q3.22

arrow
arrow

N/A

-0.29
vs -0.17

Q4.22

arrow
arrow

N/A

NA
vs NA

Q1.23

arrow
arrow

N/A

-0.03
vs -0.03

Q2.23

arrow
arrow

N/A

-0.03
vs -0.06

Q3.23

arrow
arrow

N/A

-0.06
vs -0.29

Q4.23

arrow
arrow

N/A

NA
vs NA

Q1.24

arrow
arrow

N/A

-0.02
vs -0.03

Q2.24

arrow
arrow

+100%

NA
vs -0.03

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

+21%

12.4M  vs 10.3M

Q2.22

arrow
arrow

-9%

9.7M  vs 10.6M

Q3.22

arrow
arrow

-7%

10.1M  vs 10.8M

Q4.22

arrow
arrow

-18%

8.7M  vs 10.6M

Q1.23

arrow
arrow

-5%

11.8M  vs 12.4M

Q2.23

arrow
arrow

+5%

10.2M  vs 9.7M

Q3.23

arrow
arrow

-13%

8.8M  vs 10.1M

Q4.23

arrow
arrow

+14%

10M  vs 8.7M

Q1.24

arrow
arrow

+7%

12.7M  vs 11.8M

Q2.24

arrow
arrow

-9%

9.3M  vs 10.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+130%

1.3
vs -2.26

Q4.22

arrow
arrow

+87%

0.87
vs 1.3

Q1.23

arrow
arrow

+9%

0.09
vs 0.87

Q2.23

arrow
arrow

+8%

0.08
vs 0.09

Q3.23

arrow
arrow

+8%

0.08
vs 0.08

Q4.23

arrow
arrow

+12%

0.12
vs 0.08

Q1.24

arrow
arrow

+4%

0.04
vs 0.12

Q2.24

arrow
arrow

+6%

0.06
vs 0.04

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News